Cargando…

Characteristics of ovarian tumors of low malignant potential in BRCA mutation carriers: A case series

• Tumor characteristics of 5 cases of ovarian tumor of low malignant potential (LMP) with BRCA mutation were examined. • Young age, BRCA1 mutation, and presence of invasive implants may be characteristics of BRCA carriers with ovarian LMP.

Detalles Bibliográficos
Autores principales:	Matsuo, Koji, Tierney, Katherine E., Schneider, Diane M., Mhawech-Fauceglia, Paulette, Roman, Lynda D., Gershenson, David M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563586/ https://www.ncbi.nlm.nih.gov/pubmed/26425718 http://dx.doi.org/10.1016/j.gore.2015.06.003

Ejemplares similares

Nivolumab use for BRCA gene mutation carriers with recurrent epithelial ovarian cancer: A case series
por: Matsuo, Koji, et al.
Publicado: (2018)

MET/HGF Signaling Pathway in Ovarian Carcinoma: Clinical Implications and Future Direction
por: Mhawech-Fauceglia, Paulette, et al.
Publicado: (2012)

Expression of the luteinizing hormone receptor (LHR) in ovarian cancer
por: Xiong, Shigang, et al.
Publicado: (2019)

Bilateral Ovarian Serous Borderline Tumor with Non-Invasive Endometrial Implants
por: Malham, Melissa Bou, et al.
Publicado: (2023)

The prognostic significance of GRB7 protein expression and localization in human breast and ovarian cancers
por: Vermehren-Schmaedick, Anke, et al.
Publicado: (2020)

Intersection of DNA Repair Pathways and the Immune Landscape Identifies PD-L2 as a Prognostic Marker in Epithelial Ovarian Cancer
por: Batman, Samantha, et al.
Publicado: (2021)

Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord–Stromal Tumors: A Contemporary Review
por: Maoz, Asaf, et al.
Publicado: (2020)

Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study
por: Brunette, Laurie L., et al.
Publicado: (2018)

Paratubal serous borderline tumor in an 85 years old woman: A case report
por: Mehawej, Jordy, et al.
Publicado: (2020)

PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer
por: Annunziata, Christina M, et al.
Publicado: (2010)

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
por: Zaaijer, Leendert H, et al.
Publicado: (2016)

Subcellular localization of FANCD2 is associated with survival in ovarian carcinoma
por: Joshi, Sonali, et al.
Publicado: (2020)

Elevated Expression of the Serine-Arginine Protein Kinase 1 Gene in Ovarian Cancer and Its Role in Cisplatin Cytotoxicity In Vitro
por: Odunsi, Kunle, et al.
Publicado: (2012)

Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations
por: Whittemore, A S, et al.
Publicado: (2004)

Endometrioid adenocarcinoma associated with endometrial stromal sarcoma: A rare, often unrecognized collision tumor
por: Kim, Grace, et al.
Publicado: (2015)

BRCAness Profile of Sporadic Ovarian Cancer Predicts Disease Recurrence
por: Wysham, Weiya Z., et al.
Publicado: (2012)

The PAX8 cistrome in epithelial ovarian cancer
por: Adler, Emily K., et al.
Publicado: (2017)

Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium
por: Lawrenson, Kate, et al.
Publicado: (2015)

Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers
por: Gschwantler-Kaulich, Daphne, et al.
Publicado: (2017)

Clinicopathological significance of endoplasmic reticulum stress proteins in ovarian carcinoma
por: Samanta, Soma, et al.
Publicado: (2020)

Lower extremity pain as initial presentation of cervical cancer()
por: Dandapani, Savita V., et al.
Publicado: (2013)

Time to decide about risk-reducing mastectomy: A case series of BRCA1/2 gene mutation carriers
por: McCullum, Mary, et al.
Publicado: (2007)

Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival
por: Biglia, Nicoletta, et al.
Publicado: (2016)

Co-existence of breast and ovarian cancers in BRCA germ-line mutation carriers
por: Dilawari, A, et al.
Publicado: (2008)

No Sib Pair Concordance for Breast or Ovarian Cancer in BRCA1 Mutation Carriers
por: Møller, Pål, et al.
Publicado: (2007)

Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers
por: Gschwantler-Kaulich, Daphne, et al.
Publicado: (2018)

DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer
por: Zhang, Wa, et al.
Publicado: (2015)

Claudin7 and moesin in endometrial Adenocarcinoma; a retrospective study of 265 patients
por: Mhawech-Fauceglia, Paulette, et al.
Publicado: (2012)

Expression of protein disulfide isomerase family members correlates with tumor progression and patient survival in ovarian cancer
por: Samanta, Soma, et al.
Publicado: (2017)

Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision
por: Lewis, Kelsey E., et al.
Publicado: (2018)

Targeting Src in endometriosis-associated ovarian cancer
por: Manek, R, et al.
Publicado: (2016)

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers
por: Kuchenbaecker, Karoline B., et al.
Publicado: (2017)

Management of the asymptomatic BRCA mutation carrier
por: Teller, Paige, et al.
Publicado: (2010)

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
por: Iqbal, J, et al.
Publicado: (2012)

Breast cancer risk in BRCA mutation carriers after diagnosis of epithelial ovarian cancer is lower than in carriers without ovarian cancer
por: Nañez, Andrea, et al.
Publicado: (2021)

Association between vitamin D and ovarian cancer development in BRCA1 mutation carriers
por: Pejovic, Tanja, et al.
Publicado: (2020)

Mutation Analysis of BRCA1 and BRCA2 in Italian Hereditary and Sporadic Forms of Breast and Ovarian Cancers: Tumor Genotype-Phenotype Correlation in Breast Cancer BRCA-Mutation Carriers
por: Cipollini, G., et al.
Publicado: (1999)

Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Rebbeck, Timothy R, et al.
Publicado: (2008)

Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ahmed, M, et al.
Publicado: (2010)

P53 mutations in breast and ovarian carcinomas from BRCA1 and 2 mutation carriers and noncarriers
por: Sensi, E, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_rg6nmv8f6ssurucg703pqqpujo